Abstract
Molecular imaging is critical to personalized and precision medicine. Although singly targeted imaging probes are making an impact both clinically and preclinically, molecular imaging strategies using bispecific probes have enabled improved visualization of cancer in recent years through synergistic targeting of two ligands. In this Focus on Molecular Imaging review, we outline how peptide-, antibody-, and nanoparticle-based platforms have affected this emerging strategy, providing examples and pointing out areas in which the greatest clinical impact may be realized.
Original language | English (US) |
---|---|
Pages (from-to) | 390-395 |
Number of pages | 6 |
Journal | Journal of Nuclear Medicine |
Volume | 59 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2018 |
Keywords
- Bispecific antibody fragment
- Cancer
- Dual-targeted
- Molecular imaging
- Positron emission tomography
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging